Loading
Latest filing published 16 Jan 2026 for Eledon Pharmaceuticals, Inc..
No signal scores available.
John S. McBride discloses dealings in Eledon Pharmaceuticals, Inc. to SEC (Form 4). Between 22 June 2015 and 10 January 2026, the trades on record add up to 9 filings.
Every open-market trade on record is a sale: 4 sales worth €281k. Other entries cover 5 option exercises.
The latest filing, published on 16 January 2026, reports an option exercise in Eledon Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations